info@synchemia.com | sales@synchemia.com 
9766925136 
Afatinib
Afatinib| CAS NO: 850140-72-6 , Afatinib is used to treat metastatic (cancer that has already spread) non-small cell lung cancer (NSCLC) that has certain types of abnormal epidermal growth factor receptor (EGFR) genes in patients who have not received any treatments for cancer that has already spread to other parts of the body.
We are the Synchemia Research Chemical specializes in manufacturing and supplying of Afatinib impurities that meet specific pharmacopeial standards (EP/BP/USP/IP) as well as process-related impurities. Afatinib is used to treat metastatic (cancer that has already spread) non-small cell lung cancer (NSCLC) that has certain types of abnormal epidermal growth factor receptor (EGFR) genes in patients who have not received any treatments for cancer that has already spread to other parts of the body. Buy Reliable and High-Purity Afatinib Impurities, Delivered by Synchemia Research Chemicals.
Download catalogue
Pharmaceutical Reference Standards
| CAT No | SRC-A27033 |
| CAS No | 2223677-58-3 |
| Mol.F. | C22H20ClFN4O4 |
| Mol.Wt. | 458.9g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-A27034 |
| CAS No | 1086268-91-8 |
| Mol.F. | C8H15NO2 : HCl |
| Mol.Wt. | 157.2 : 36.5g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-A27035 |
| CAS No | 212776-19-7 |
| Mol.F. | C7H13NO2 |
| Mol.Wt. | 143.2g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-A27036 |
| CAS No | 314771-88-5 |
| Mol.F. | C18H14ClFN4O4 |
| Mol.Wt. | 404.8g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-A27037 |
| CAS No | 618061-76-0 |
| Mol.F. | C24H27ClFN4O6P |
| Mol.Wt. | 552.9g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-A27038 |
| CAS No | NA |
| Mol.F. | C22H20ClFN4O4 |
| Mol.Wt. | 458.9g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
Let’s advance your research together.
Partner with us for specialized chemical materials and synthesis services that enable pharmaceutical innovation.
